TORC1 inhibition enhances immune function and reduces infections in the elderly

Science Translational Medicine
Joan B MannickLloyd B Klickstein

Abstract

Inhibition of the mechanistic target of rapamycin (mTOR) protein kinase extends life span and ameliorates aging-related pathologies including declining immune function in model organisms. The objective of this phase 2a randomized, placebo-controlled clinical trial was to determine whether low-dose mTOR inhibitor therapy enhanced immune function and decreased infection rates in 264 elderly subjects given the study drugs for 6 weeks. A low-dose combination of a catalytic (BEZ235) plus an allosteric (RAD001) mTOR inhibitor that selectively inhibits target of rapamycin complex 1 (TORC1) downstream of mTOR was safe and was associated with a significant (P = 0.001) decrease in the rate of infections reported by elderly subjects for a year after study drug initiation. In addition, we observed an up-regulation of antiviral gene expression and an improvement in the response to influenza vaccination in this treatment group. Thus, selective TORC1 inhibition has the potential to improve immune function and reduce infections in the elderly.

References

Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Feb 13, 2009·PLoS Biology·Morris E FeldmanKevan M Shokat
May 18, 2011·Molecular and Cellular Biology·Beat NyfelerLeon O Murphy
Apr 17, 2012·Cell·Mathieu Laplante, David M Sabatini
Jan 18, 2013·Nature·Simon C JohnsonMatt Kaeberlein
Jun 12, 2013·Cell·Carlos López-OtínGuido Kroemer
Feb 4, 2014·Genome Biology·Charity W LawGordon K Smyth
Jul 26, 2014·Aging Cell·Dudley W LammingDavid M Sabatini
Dec 3, 2014·Endocrinology·Graham DominickGonzalo G Garcia
Dec 30, 2014·Science Translational Medicine·Joan B MannickLloyd B Klickstein
Jan 24, 2015·Nature Reviews. Immunology·Finlay McNabAnne O'Garra
Feb 11, 2016·Journal of Racial and Ethnic Health Disparities·Bijou Hunt, Steve Whitman

❮ Previous
Next ❯

Citations

Aug 8, 2018·Nature Reviews. Immunology·Alexandra Flemming
Nov 6, 2018·Clinical Pharmacology and Therapeutics·Ram R Miller, Ronenn Roubenoff
Jan 10, 2019·PLoS Computational Biology·Matías FuentealbaLinda Partridge
Apr 12, 2019·Expert Opinion on Drug Discovery·A Myers, G J Lithgow
Feb 23, 2019·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Sabrina N Dumas, Dudley W Lamming
Jun 9, 2019·International Journal of Molecular Sciences·Giovanni StalloneGiuseppe Grandaliano
Aug 2, 2019·Cell Cycle·Mikhail V Blagosklonny
Aug 23, 2019·Science Translational Medicine·Christophe LechauveMitchell J Weiss
Sep 4, 2019·Nature Reviews. Nephrology·Yuki Sato, Motoko Yanagita
Jul 10, 2019·Journal of the American Geriatrics Society·John C NewmanRobert J Pignolo
Oct 18, 2019·Traffic·Sadia RahmaniCostin N Antonescu
Dec 11, 2019·Cells·Cedric MagawayEstela Jacinto
Nov 7, 2019·Nature Reviews. Genetics·David MelzerLuigi Ferrucci
Dec 12, 2019·Expert Opinion on Drug Discovery·Alexey Moskalev
Sep 19, 2019·Interdisciplinary Sciences, Computational Life Sciences·Mohammadreza DorvashIman Tavassoly
Mar 17, 2020·EMBO Molecular Medicine·Jean-Marc CavaillonTomasz Skirecki
Apr 16, 2020·Journal of the American Geriatrics Society·Felipe Sierra
Apr 29, 2020·ELife·Jonathan Y AnMatt Kaeberlein
May 2, 2020·Cells·Burkitkan AkbaySvetlana Dokudovskaya
Jun 9, 2019·Nature Reviews. Immunology·Niharika A DuggalJanet M Lord
Jun 13, 2019·Nature Reviews. Immunology·Jörg J Goronzy, Cornelia M Weyand
May 30, 2020·Nature Reviews. Drug Discovery·Linda PartridgeBrian K Kennedy
Jul 12, 2019·Nature·Judith CampisiEric Verdin
Jul 29, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Young-Mi GoYan Chen
Nov 19, 2018·Aging·Mikhail V Blagosklonny
Nov 6, 2018·Aging·Na Yang, Payel Sen
Oct 7, 2019·Aging·Mikhail V Blagosklonny
Mar 14, 2020·Aging·Ellen K Quarles, Peter S Rabinovitch
Jun 14, 2020·Aging·Mikhail V Blagosklonny
May 30, 2020·Aging·Amber L MuellerDavid A Sinclair
Jun 17, 2020·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Shabnam Salimi, John M Hamlyn
Jun 30, 2019·European Journal of Nutrition·A KalacheJ C Griffiths
Dec 14, 2019·Clinical & Translational Immunology·Kylie M QuinnNicole L La Gruta
Oct 22, 2019·Frontiers in Cell and Developmental Biology·Fernando Macian
Jan 16, 2020·Nature Reviews. Molecular Cell Biology·Grace Y Liu, David M Sabatini
Mar 13, 2020·Nature Reviews. Endocrinology·Sundeep KhoslaJames L Kirkland
Aug 5, 2018·Science Immunology·Rachael A Clark
Aug 14, 2019·Cell Death & Disease·Mikhail V Blagosklonny
Jul 22, 2019·Nature Communications·Katherine H SchreiberDudley W Lamming

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Science Translational Medicine
Joan B MannickLloyd B Klickstein
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
Brian J MorrisBradley J Willcox
Indian Journal of Dermatology, Venereology and Leprology
Debopam Samanta
© 2022 Meta ULC. All rights reserved